-
Product Insights
Insomnia Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Insomnia - Global Clinical Trials Review, 2025" provides an overview of Insomnia Clinical trials scenario. This report provides top line data relating to the clinical trials on Insomnia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
Prostate Cancer Epidemiology Analysis and Forecast to 2033
Prostate cancer is a malignancy in the prostate gland, which is located below the bladder and in front of the rectum in males. Worldwide, about 1.4 million men were diagnosed with prostate cancer in 2020 (Wang et al., 2022). In the US, prostate cancer is the most common cancer in men after skin cancer, and it is the third most common cause of cancer death in men (Siegel et al., 2020). Approximately one in seven American men are diagnosed with...
-
Sector Analysis
Severe Asthma in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033
This new set to update and replace the previous asthma market analysis publication, Asthma: Global Drug Forecast and Market Analysis to 2029 (December 2020, GDHC208PIDR), which covered the forecast period 2019–29. This new publication covers the severe asthma market over the forecast period of 2023-33. GlobalData estimated the total severe asthma market to be valued at $5.1 billion across the 8MM, with the US accounting for 80.4% of the market. The five major European markets (5EU) (France, Germany, Italy, Spain,...
-
Thematic Analysis
US Elections – Trump Tariffs (Fourth Edition) - Strategic Intelligence
This edition focuses on the policy of the new Trump administration that will have the strongest and most wide-ranging impact on the global economy, namely tariffs. This policy revolves around increases – threatened and actual – in the tariff rates levied on imports into the US. How Trump’s tariff campaign plays out will affect businesses’ US market access and profitability, along with the timing and location of investment decisions, in major industry sectors worldwide.​ This edition focuses on the policy...
-
Sector Analysis
Fragile X Syndrome Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2030
This report covers the US and Germany and provides an Excel-based forecast model for the Fragile X Syndrome market through 2030. The FXS market in the US and Germany for 2025 is valued at $28.7 million. The market is projected to grow at a compound annual growth rate (CAGR) of 14.7% between 2020 and 2030, reaching $111.9 million by 2030. The introduction of two pipeline agents is a major driver of growth of the FXS market. In order of entry,...
-
Sector Analysis
Duchenne Muscular Dystrophy Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2033
This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the DMD market through 2033. Duchenne muscular dystrophy (DMD) is a rare genetic disorder characterized by progressive muscle degeneration due to mutations in the dystrophin gene. Dystrophin is part of a group of proteins, which together form the dystrophin-associated protein complex (DPC). These proteins form a transmembrane scaffold that is crucial for the structure of the muscle tissue, protecting muscle fibers...
-
Thematic Analysis
43rd Annual JP Morgan Healthcare Conference, January 13–16, 2025
The 43rd Annual JP Morgan Healthcare Conference took place in San Francisco, California on January 13-16, 2025. The event is the largest and most informative health care investment symposium in the industry. This year’s invitation-only conference provided key insights into the evolving strategies, pipeline advancements, and market trends shaping the biopharmaceutical industry, including acquisitions, innovative pipeline developments, and strategic shifts to navigate a rapidly changing healthcare landscape. In this report GlobalData provides an in-depth analysis of the key themes, strategic...
-
Sector Analysis
Target Validation for Genetic Targets - Innovation Insights, Competitive Analysis, Patents, Drugs, Clinical Trials and Deals
Target validation is a crucial step in the drug discovery process, especially when it comes to genetic targets. This process involves confirming that a specific gene or protein is indeed involved in the disease pathway and is a viable target for therapeutic intervention. In this topic, we will explore the various methods and approaches used for target validation, including genetic knockout studies, RNA interference, and small molecule inhibitors. We will also discuss the challenges and limitations of target validation, as...
-
Sector Analysis
siRNA Gene Silencing - Innovation Insights, Competitive Analysis, Patents, Drugs, Clinical Trials and Deals
siRNA gene silencing is a powerful technique used in molecular biology to selectively silence the expression of specific genes. Small interfering RNAs (siRNAs) are short double-stranded RNA molecules that can bind to complementary messenger RNA (mRNA) sequences and trigger their degradation, preventing the translation of the corresponding protein. This process, known as RNA interference (RNAi), allows researchers to study the function of individual genes and potentially develop new therapeutic strategies for treating genetic diseases or cancer. By designing siRNAs that...
-
Sector Analysis
Engineered Exosomes - Innovation Insights, Competitive Analysis, Patents, Drugs, Clinical Trials and Deals
Engineered exosomes are small vesicles secreted by cells that have been modified to carry specific cargo, such as drugs or therapeutic molecules. These engineered exosomes have shown great potential as delivery vehicles for targeted therapy in various diseases, including cancer, neurodegenerative disorders, and inflammatory conditions. By loading exosomes with therapeutic agents and targeting them to specific cells or tissues, researchers aim to improve the efficacy and reduce the side effects of traditional drug delivery methods. This emerging field of research...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.